Cargando…
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
(1) Background: Numerous vaccines are under preclinical and clinical development for prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In light of high efficacy rates and satisfactory safety profiles, some agents have already reached approval and are now distribu...
Autores principales: | Niebel, Dennis, Novak, Natalija, Wilhelmi, Jasmin, Ziob, Jana, Wilsmann-Theis, Dagmar, Bieber, Thomas, Wenzel, Joerg, Braegelmann, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470727/ https://www.ncbi.nlm.nih.gov/pubmed/34579181 http://dx.doi.org/10.3390/vaccines9090944 |
Ejemplares similares
-
Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines
por: Niebel, Dennis, et al.
Publicado: (2021) -
Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients—Focus on Clinical and Histopathological Variation
por: Niebel, Dennis, et al.
Publicado: (2022) -
Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?
por: Niebel, Dennis, et al.
Publicado: (2021) -
Specialized dermatological-rheumatological patient management improves diagnostic outcome and patient journey in psoriasis and psoriatic arthritis: a four-year analysis
por: Ziob, Jana, et al.
Publicado: (2021) -
Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
por: Niebel, Dennis, et al.
Publicado: (2021)